Top

Gepubliceerd in:

01-02-2015

Parodontitis als risicofactor voor diabetes type 2 en hart- en vaatziekten

Auteurs: Dr. W. Nesse, Prof. dr. F.K.L. Spijkervet, Dr. Y.I.G.V. Tichelaar, Prof. dr. A. Vissink

Gepubliceerd in: Bijblijven | Uitgave 1/2015

Samenvatting

Van parodontitis, een ontsteking van de weefsels rondom de tand, is bekend dat het de mondgezondheid en de algehele gezondheid negatief kan beïnvloeden. Parodontitis veroorzaakt een ulcererend wondoppervlak: hoe groter dat wondoppervlak is, hoe groter de kans dat mondbacteriën en ontstekingsmediatoren via het wondoppervlak in de bloedbaan terechtkomen en bijvoorbeeld de stolling en het metabolisme ontregelen. Parodontitis, diabetes type 2 en hart- en vaatziekten vormen een groep aandoeningen met dezelfde risicofactoren die elkaar wederzijds lijken te beïnvloeden. Patiënten met diabetes mellitus type 2 en hart- en vaatziekte lijden vaak ook aan parodontitis. Behandeling van parodontitis bij diabetes type 2-patiënten kan resulteren in een klinisch relevante daling van de HbA_1c. Voorts resulteert een behandeling van parodontitis in een daling van surrogaatmarkers voor hart- en vaatziekten, zoals CRP. In het kader van bevordering van de algehele gezondheid, is verwijzing door de huisarts naar de tandarts of mondhygiëniste op zijn plaats van patiënten met diabetes type 2 en hart- en vaatziekte voor screening op en eventuele behandeling van parodontitis.

vorige artikel Bijwerkingen van medicatie: uitingen in het het hoofd-halsgebied

volgende artikel Het syndroom van Sjögren

American Academy of Periodontology. Position paper: epidemiology of periodontal diseases. J Periodontol 2005;76:1406-19.CrossRef

Baehni P, Tonetti MS, Group 1 of the European Workshop on Periodontology. Conclusions and consensus statements on periodontal health, policy and education in Europe: a call for action – consensus view 1. Consensus report of the 1st European Workshop on Periodontal Education. Eur J Dent Educ 2010;14(Suppl. 1):2-3.CrossRefPubMed

Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ, CDC Periodontal Disease Surveillance Workgroup: James Beck (University of North Carolina, Chapel Hill, USA), Gordon Douglass (Past President, American Academy of Periodontology), Roy Page (University of Washington). Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res 2012;91:914-20.CrossRefPubMed

Lagervall M, Jansson L. Relationship between tooth loss/probing depth and systemic disorders in periodontal patients. Swed Dent J 2007;31:1-9.PubMed

Feitosa DS, Marques MR, Casati MZ, Sallum EA, Nociti FH, Jr., Toledo S de. The influence of thyroid hormones on periodontitis-related bone loss and tooth-supporting alveolar bone: a histological study in rats. J Periodontal Res 2009;44:472-8.CrossRefPubMed

Piconi S, Trabattoni D, Luraghi C, et al. Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima-media thickness. FASEB J 2009;23:1196-204.CrossRefPubMed

Tonetti MS. Periodontitis and risk for atherosclerosis: an update on intervention trials. J Clin Periodontol 2009;36(Suppl. 10):15-9.CrossRefPubMed

Humphrey LL, Fu R, Buckley DI, Freeman M, Helfand M. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J Gen Intern Med 2008;23:2079-86.CrossRefPubMedCentralPubMed

Friedewald VE, Kornman KS, Beck JD, et al. The American Journal of Cardiology and Journal of Periodontology editors’ consensus: periodontitis and atherosclerotic cardiovascular disease (diamond). J Periodontol 2009;80:1021-32.CrossRefPubMed

10.

Franek E, Klamczynska E, Ganowicz E, Blach A, Budlewski T, Gorska R. Association of chronic periodontitis with left ventricular mass and central blood pressure in treated patients with essential hypertension. Am J Hypertens 2009;22:203-7CrossRefPubMed

11.

Janket SJ, Baird AE, Chuang SK, Jones JA. Meta-analysis of periodontal disease and risk of coronary heart disease and stroke. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:559-69.CrossRefPubMed

12.

Choe H, Kim YH, Park JW, Kim SY, Lee SY, Jee SH. Tooth loss, hypertension and risk for stroke in a Korean population. Atherosclerosis 2009;203:550-6.CrossRefPubMed

13.

Taylor GW, Burt BA, Becker MP, et al. Severe periodontitis and risk for poor glycemic control in patients with noninsulin-dependent diabetes mellitus. J Periodontol 1996;67:1085-93.CrossRefPubMed

14.

Saremi A, Nelson RG, Tulloch-Reid M, et al. Periodontal disease and mortality in type 2 diabetes. Diabetes Care 2005;28:27-32.CrossRefPubMed

15.

Chávarry NG, Vettore MV, Sansone C, Sheiham A. The relationship between diabetes mellitus and destructive periodontal disease: a meta-analysis. Oral Health Prev Dent 2009;7:107-27.PubMed

16.

Katagiri S, Nitta H, Nagasawa T, et al. Multi-center intervention study on glycohemoglobin (HbA1c) and serum, high-sensitivity CRP (hs-CRP) after local anti-infectious periodontal treatment in type 2 diabetic patients with periodontal disease. Diabetes Res Clin Pract 2009;83:308-15.CrossRefPubMed

17.

Nesse W, Linde A, Abbas F, et al. Dose-response relationship between periodontal inflamed surface area and HbA1c in type 2 diabetics. J Clin Periodontol 2009;36:295-300.CrossRefPubMed

18.

Wang TT, Chen TH, Wang PE, et al. A population-based study on the association between type 2 diabetes and periodontal disease in 12,123 middle-aged Taiwanese (KCIS No. 21). J Clin Periodontol 2009;36:372-9.CrossRefPubMed

19.

Gold SI. Periodontics. The past. Part I. Early sources. J Clin Periodontol 1985;12(2):79-97.CrossRefPubMed

20.

O’Reilly PG, Claffey NM. A history of oral sepsis as a cause of disease. Periodontol 2000 2000;23:13-8.CrossRefPubMed

21.

Miller WD. The human mouth as a focus of infection. Dent Cosmos 1891;33:188-32.

22.

Billings F. Focal infection: the lane medical lectures. New York: Appleton and Company; 1916.

23.

Mattila K, Rasi V, Nieminen M, Valtonen V, Kesaniemi A, Syrjala S, et al. von Willebrand factor antigen and dental infections. Thromb Res 1989;56(2):325-9.CrossRefPubMed

24.

Syrjanen J, Peltola J, Valtonen V, Livanainen M, Kaste M, Huttunen JK. Dental infections in association with cerebral infarction in young and middle-aged men. J Intern Med 1989;225(3):179-84.CrossRefPubMed

25.

Bahekar AA, Singh S, Saha S, Molnar J, Arora R. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 2007;154(5):830-7.CrossRefPubMed

26.

Blaizot A, Vergnes JN, Nuwwareh S, Amar J, Sixou M. Periodontal diseases and cardiovascular events: meta-analysis of observational studies. Int Dent J 2009;59(4):197-209.PubMed

27.

Simpson TC, Needleman I, Wild SH, Moles DR, Mills EJ. Treatment of periodontal disease for glycaemic control in people with diabetes. Cochrane Database Syst Rev 2010;(5):CD004714.

28.

Teeuw WJ, Gerdes VE, Loos BG. Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis. Diabetes Care 2010;33(2):421-7.CrossRefPubMedCentralPubMed

29.

Chiu B. Multiple infections in carotid atherosclerotic plaques. Am Heart J 1999;138(5 Pt. 2):S534-6.CrossRefPubMed

30.

Boggess KA, Moss K, Madianos P, Murtha AP, Beck J, Offenbacher S. Fetal immune response to oral pathogens and risk of preterm birth. Am J Obstet Gynecol 2005;193(3 Pt. 2):1121-6.CrossRefPubMed

31.

Mustapha IZ, Debrey S, Oladubu M, Ugarte R. Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis. J Periodontol 2007;78(12):2289-302.CrossRefPubMed

32.

Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008;35(4):277-90.CrossRefPubMed

33.

Engebretson S, Chertog R, Nichols A, Hey-Hadavi J, Celenti R, Grbic J. Plasma levels of tumour necrosis factor-alpha in patients with chronic periodontitis and type 2 diabetes. J Clin Periodontol 2007;34(1):18-24.CrossRefPubMed

34.

Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286(3):327-34.CrossRefPubMed

35.

Saito T, Shimazaki Y, Kiyohara Y, Kato I, Kubo M, Iida M, et al. The severity of periodontal disease is associated with the development of glucose intolerance in non-diabetics: the Hisayama study. J Dent Res 2004;83(6):485-90.CrossRefPubMed

36.

Buhlin K, Hultin M, Norderyd O, Persson L, Pockley AG, Rabe P, et al. Risk factors for atherosclerosis in cases with severe periodontitis. J Clin Periodontol 2009;36(7):541-9.CrossRefPubMed

37.

Vidal F, Figueredo CM, Cordovil I, Fischer RG. Periodontal therapy reduces plasma levels of interleukin-6, C-reactive protein, and fibrinogen in patients with severe periodontitis and refractory arterial hypertension. J Periodontol 2009;80(5):786-91.CrossRefPubMed

38.

Oliveira C de, Watt R, Hamer M. Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey. BMJ (Clinical Research Ed.) 2010;340:c2451.CrossRef

39.

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352(9131):837-53.

40.

Engebretson SP, Hyman LG, Michalowicz BS, Schoenfeld ER, Gelato MC, Hou W, Seaquist ER, Reddy MS, Lewis CE, Oates TW, Tripathy D, Katancik JA, Orlander PR, Paquette DW, Hanson NQ, Tsai MY. The effect of nonsurgical periodontal therapy on hemoglobin A1c levels in persons with type 2 diabetes and chronic periodontitis: a randomized clinical trial. JAMA 2013;310(23):2523-32.CrossRefPubMedCentralPubMed

41.

CBS Doodsoorzaakstatistieken (http://www.nationaalkompas.nl/gezondheid-en-ziekte/ziekten-en-aandoeningen/wat-zijn-de-belangrijkste-doodsoorzaken/); 2015, 9 februari.

42.

Teeuw WJ, Slot DE, Susanto H, Gerdes VEA, Abbas F, D’Aiuto F, Kastelein JJP, Loos BG. Treatment of periodontitis improves the atherosclerotic profile: a systematic review and meta-analysis. J Clin Periodontol 2014;41:70-9.CrossRefPubMed

43.

International Diabetes Federation. Electronic version of diabetes atlas (http://www.idf.org/complications-diabetes); 2015, 9 februari.

44.

Furukawa T, Wakai K, Yamanouchi K, et al. Associations of periodontal damage and tooth loss with atherogenic factors among patients with type 2 diabetes mellitus. Intern Med 2007;46:1359-64.CrossRefPubMed

45.

Ryan ME, Carnu O, Kamer A. The influence of diabetes on the periodontal tissue. J Am Dent Assoc 2003;134:34S-40S.CrossRefPubMed

46.

Mealy BL, Oates TW. Diabetes and periodontal diseases. J Periodontol 2006;77:1289-303.CrossRef

47.

Soell M, Hassan M, Miliauskaite A, Haikel Y, Selimovic D. The oral cavity of elderly patients in diabetes. Diabetes Metab 2007;33:S10-S18.CrossRefPubMed

48.

Janket SJ, Jones JA, Meurman JH, Baird AE, Dyke TE Van. Oral infection, hyperglycemia, and endothelial dysfunction. Oral Surg Oral Med Oral Pathol Oral Rad Endod 2008;105:173-17.CrossRef

49.

Wannamethee SG, Tchernova J, Whincup P, Lowe GD, Kelly A, Rumley A, Wallace AM, Sattar N. Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis 2007;191:418-26.CrossRefPubMed

50.

Nibali L, Tatarakis N, Needleman I, Tu YK, D’Aiuto F, Rizzo M, Donos N. Clinical review: association between metabolic syndrome and periodontitis: a systematic review and meta-analysis. J Clin Endocrinol Metab 2013;98(3):913-20.CrossRefPubMed

51.

Nesse W, Abbas F, Ploeg I van der, Spijkervet FK, Dijkstra PU, Vissink A. Periodontal inflamed surface area: quantifying inflammatory burden. J Clin Periodontol 2008;35(8):668-73.CrossRefPubMed

Titel: Parodontitis als risicofactor voor diabetes type 2 en hart- en vaatziekten
Auteurs: Dr. W. Nesse
Prof. dr. F.K.L. Spijkervet
Dr. Y.I.G.V. Tichelaar
Prof. dr. A. Vissink
Publicatiedatum: 01-02-2015
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Bijblijven / Uitgave 1/2015
Print ISSN: 0168-9428
Elektronisch ISSN: 1876-4916
DOI: https://doi.org/10.1007/s12414-015-0006-4

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen

Andere artikelen Uitgave 1/2015

Temporomandibulaire disfunctie

(Professionele) mondzorg bij de oudere patiënt

Algemene introductie

Slijmvliesafwijkingen van de mond

Redactioneel ten geleide

Het syndroom van Sjögren